Clinical Trial Update: Japan Long-term Safety for Tiotropium Plus Olodaterol [Phase 3]

View source ↗

Summary

This clinical trial update reports long-term safety results from a Phase 3 study of the tiotropium plus olodaterol combination for chronic obstructive pulmonary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)
• Striverdi Respimat (olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2015-07-15